Every artery-clogging lipoprotein in your blood carries exactly one copy of a protein called apolipoprotein B. One particle, one ApoB. So when a lab measures your ApoB, it is counting the actual number of particles that can burrow into an artery wall and start a plaque. That is the thing standard cholesterol panels only estimate, and sometimes estimate badly.
Most people have spent their lives watching LDL cholesterol, the amount of cholesterol packed inside those particles. But cholesterol is the cargo, not the vehicle. Two people can carry the same LDL-C while one has far more particles doing the damage. The count matters more than the load.
What a particle actually does to an artery
Atherosclerosis is not a plumbing problem where fat gloms onto the pipe from inside. It is a retention problem. ApoB-containing particles (LDL, VLDL remnants, Lp(a), IDL) small enough to slip through the endothelium get trapped in the artery wall, oxidize, and trigger an immune response that builds plaque over decades. The more particles crossing the border per day, the more get stuck. This is why the causal story runs through particle number rather than the cholesterol each one happens to be carrying.
The genetic evidence here is unusually clean. People who inherit lifelong lower ApoB have dramatically less heart disease, and the risk tracks cumulative exposure to particles over time, not a single snapshot. The European Atherosclerosis Society laid this out in a consensus statement arguing that LDL and other ApoB lipoproteins are not just associated with cardiovascular disease but cause it, based on genetics, epidemiology, and trials pointing the same direction Eur Heart J, 2017.
Where LDL-C quietly lies
The trouble comes when LDL-C and ApoB disagree, which happens more than you would think. This is called discordance. If your particles are small and cholesterol-poor, common in insulin resistance, high triglycerides, and metabolic syndrome, you can have a reassuring LDL-C of 100 mg/dL while your particle count sits in the danger zone. Your bloodwork says fine. Your arteries disagree.
When the two numbers conflict, ApoB wins as a risk predictor. A meta-analysis comparing LDL-C, non-HDL-C, and ApoB found ApoB was the strongest of the three at predicting cardiovascular events Circ Cardiovasc Qual Outcomes, 2011. And in the INTERHEART study, which examined first heart attacks across 52 countries, the ratio of ApoB to ApoA1 was the single most powerful lipid marker of risk, beating standard cholesterol measures Lancet, 2008.
This matters most for exactly the people who feel safe. Lean, active, normal LDL-C, but with creeping triglycerides and shrinking HDL. That pattern hides a high particle count, and it is the pattern a routine panel is worst at catching. If you are tracking your metabolic health with a CGM or watching fasting glucose, ApoB belongs on the same page.
What the numbers look like
ApoB is measured in mg/dL and is cheap, standardized, and does not require fasting. Here is a rough map of where values fall and what they signal. Targets get stricter the more cardiovascular risk you already carry.
| ApoB (mg/dL) | Interpretation |
|---|---|
| Below 60 | Optimal, roughly the level seen in populations with very low heart disease |
| 60 to 80 | Good, a reasonable target for most healthy adults |
| 80 to 100 | Average for a Western adult, higher than ideal |
| 100 to 120 | Elevated, worth acting on |
| Above 120 | High, particle burden driving meaningful risk |
For context, an ApoB near 80 mg/dL corresponds loosely to an LDL-C around 100, but that conversion breaks down precisely when discordance is present, which is the whole reason to measure it directly. People with existing heart disease or diabetes are often pushed well below 65.
What to do on Monday
Ask for the test by name. It is a single blood draw, no fasting required, covered by most labs, and it costs a fraction of the fancier particle-imaging panels. If your doctor only ordered a standard lipid panel, ApoB is a reasonable add-on request, especially if your triglycerides run above 130 or you have any metabolic red flags.
The levers that lower particle count are the ones you already know, and they work. Reducing saturated fat and refined carbohydrate lowers ApoB. Soluble fiber pulls it down by binding bile acids, another reason the fiber gap is worth closing. Losing visceral fat improves the small-dense-particle pattern that causes discordance in the first place. And if lifestyle is not enough, statins and other lipid-lowering drugs reduce ApoB directly, which is ultimately how they reduce heart attacks.
One honest caveat: your first ApoB is a starting line, not a verdict. Because atherosclerosis reflects cumulative exposure, a single reading above 120 does not doom you, and a single good one does not exempt you. The trend over years is what shapes your arteries.
Where the evidence stops
ApoB counts particles but does not tell you Lp(a), a genetically driven, especially sticky particle that carries its own risk and needs a separate one-time test. It also cannot see a plaque that already exists, which is what a coronary artery calcium scan is for. ApoB tells you how fast you are adding fuel to the fire. It does not tell you how big the fire already is. For that reason the sharpest picture comes from pairing an ApoB with a CAC score, one measuring the ongoing insult and the other measuring the accumulated damage.